In the unadjusted logistic regression, the odds of a false positive result were higher for the 1,108 test kits used ≤1 month before expiration, compared to 1,251 kits with ≥6 months until expiration (Odds Ratio (OR) 14.8, 95% CI 1.94 113.6, p = 0.009).
In this case, two high functionalizations were selected to be reducing the product content volume and extending the product expiration date, compared with those of conventional packaging.
The improvement in oxygenation that we observed in two patients could be accounted for by the lack of disconnection from the ventilator and the lack of active expiration as compared with the super syringe procedure.
During forced maximum breathing, only COPD patients with severe COPD (GOLD stage 3) showed significant differences in ΔF at maximum inspiration and expiration compared to healthy subjects (p = 0.0008).
An average of three consecutive bolus (10 ml) TDco measurements made during end-expiration was compared with corresponding NICO measurements.
During ventilation with FLEX the no-flow phase in late expiration was reduced by 50% compared with passive expiration.
With PSV, RVOT VTI was equal during inspiration and expiration only with PSVlow but it was clearly lower during inspiration compared with expiration with PSVal and PSVhigh (P < 0.001, level*mode interaction).
The highest RVOT VTI during inspiration compared with expiration was observed with NAVAal (109 ± 5%).
Inspiration caused a significant decrease of Acmean compared with expiration during CMV (Table 1).
